Shota Ida

538 total citations
30 papers, 393 citations indexed

About

Shota Ida is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Shota Ida has authored 30 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Immunology and 9 papers in Cancer Research. Recurrent topics in Shota Ida's work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer Cells and Metastasis (9 papers) and Head and Neck Cancer Studies (8 papers). Shota Ida is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Cancer Cells and Metastasis (9 papers) and Head and Neck Cancer Studies (8 papers). Shota Ida collaborates with scholars based in Japan, United States and Malaysia. Shota Ida's co-authors include Kazuaki Chikamatsu, Hideyuki Takahashi, Hiroe Tada, Reika Kawabata‐Iwakawa, Masato Shino, Koichi Sakakura, Yasushi Maeda, Shinji Sugihara, Satoshi Irie and Tomoyuki Kawada and has published in prestigious journals such as Scientific Reports, Polymer and Cancer Science.

In The Last Decade

Shota Ida

27 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shota Ida Japan 12 193 118 101 89 82 30 393
Mary‐Keara Boss United States 11 161 0.8× 64 0.5× 66 0.7× 142 1.6× 205 2.5× 41 616
Megan E. Cavanaugh United States 8 317 1.6× 50 0.4× 104 1.0× 116 1.3× 106 1.3× 10 488
Almudena García‐Castaño Spain 11 204 1.1× 58 0.5× 68 0.7× 193 2.2× 188 2.3× 30 496
Jared M. Newton United States 12 184 1.0× 55 0.5× 140 1.4× 166 1.9× 54 0.7× 19 424
Tianzhu Yu China 12 100 0.5× 106 0.9× 33 0.3× 287 3.2× 97 1.2× 24 571
Shu‐Yun Ma China 14 156 0.8× 106 0.9× 75 0.7× 198 2.2× 45 0.5× 45 456
Pontus K.E. Börjesson Netherlands 8 189 1.0× 21 0.2× 38 0.4× 125 1.4× 118 1.4× 9 522
Elly De Vlieghere Belgium 12 212 1.1× 112 0.9× 62 0.6× 155 1.7× 46 0.6× 26 480
Xiumei Ma China 12 124 0.6× 108 0.9× 76 0.8× 181 2.0× 110 1.3× 34 473
Thomas Sroka United States 10 101 0.5× 24 0.2× 30 0.3× 283 3.2× 79 1.0× 18 500

Countries citing papers authored by Shota Ida

Since Specialization
Citations

This map shows the geographic impact of Shota Ida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shota Ida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shota Ida more than expected).

Fields of papers citing papers by Shota Ida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shota Ida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shota Ida. The network helps show where Shota Ida may publish in the future.

Co-authorship network of co-authors of Shota Ida

This figure shows the co-authorship network connecting the top 25 collaborators of Shota Ida. A scholar is included among the top collaborators of Shota Ida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shota Ida. Shota Ida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chikamatsu, Kazuaki, et al.. (2025). Circulating Tumor Cells in Head and Neck Squamous-Cell Carcinoma Exhibit Distinct Properties Based on Targeted Epithelial-Related Markers. Current Issues in Molecular Biology. 47(4). 240–240. 1 indexed citations
2.
Musha, Atsushi, Nobuteru Kubo, Hidemasa Kawamura, et al.. (2023). Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy. Cancer Reports. 6(7). e1825–e1825. 5 indexed citations
3.
Musha, Atsushi, Nobuteru Kubo, Naoko Okano, et al.. (2022). The Efficacy of Radiotherapy without Surgery for External Auditory Canal Squamous Cell Carcinoma. Journal of Clinical Medicine. 11(19). 5905–5905. 5 indexed citations
5.
Takahashi, Hideyuki, Reika Kawabata‐Iwakawa, Shota Ida, et al.. (2022). Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma. Oral Oncology. 136. 106270–106270. 28 indexed citations
6.
Musha, Atsushi, Nobuteru Kubo, Hidemasa Kawamura, et al.. (2022). Carbon-ion Radiotherapy for Inoperable Head and Neck Bone and Soft-tissue Sarcoma: Prospective Observational Study. Anticancer Research. 42(3). 1439–1446. 8 indexed citations
7.
Tada, Hiroe, Hideyuki Takahashi, Kanae Yamada, et al.. (2021). Dynamic alterations of circulating T lymphocytes and the clinical response in patients with head and neck squamous cell carcinoma treated with nivolumab. Cancer Immunology Immunotherapy. 71(4). 851–863. 9 indexed citations
8.
Yamada, Kanae, Shota Ida, Hiroe Tada, et al.. (2021). In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkworms. Journal of Materials Science Materials in Medicine. 32(6). 58–58. 5 indexed citations
10.
Tada, Hiroe, et al.. (2021). The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma. Anticancer Research. 41(2). 885–893. 4 indexed citations
11.
Takahashi, Hideyuki, et al.. (2021). Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma. Scientific Reports. 11(1). 17789–17789. 29 indexed citations
12.
Tada, Hiroe, et al.. (2021). Systemic immune responses are associated with molecular characteristics of circulating tumor cells in head and neck squamous cell carcinoma. Molecular and Clinical Oncology. 15(1). 147–147. 3 indexed citations
14.
Tada, Hiroe, Hideyuki Takahashi, Reika Kawabata‐Iwakawa, et al.. (2020). Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma. Scientific Reports. 10(1). 21573–21573. 16 indexed citations
15.
16.
Ida, Shota, et al.. (2020). Human Papillomavirus-related Sinonasal Carcinoma: Report of Two Cases. Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology). 59(4). 363–369. 1 indexed citations
17.
Suzuki, Masami, Shota Ida, Keita Mori, et al.. (2018). Association Between Laryngopharyngeal Reflux and Radiation-induced Mucositis in Head and Neck Cancer. Anticancer Research. 38(1). 477–480. 4 indexed citations
18.
Chikamatsu, Kazuaki, Hiroe Tada, Hideyuki Takahashi, et al.. (2018). Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma. Oral Oncology. 89. 34–39. 34 indexed citations
19.
Suzuki, Masami, et al.. (2016). Successful treatment of radiation-induced mucositis with proton pump inhibitor administration: A report of two laryngeal cancer cases. Auris Nasus Larynx. 44(1). 122–125. 6 indexed citations
20.
Takahashi, Hideyuki, et al.. (2016). Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy. Cancer Science. 107(8). 1065–1071. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026